Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,390 | -25,412 | -21,481 | -15,553 | -10,385 |
| Depreciation Amortization | 400 | 3,503 | 3,078 | 1,978 | 1,007 |
| Accounts receivable | 254 | -1,844 | -2,178 | -554 | -132 |
| Other Working Capital | 4,584 | -2,530 | -6,905 | 2,892 | -4,753 |
| Other Operating Activity | -1,443 | -9,664 | -6,902 | -6,448 | -488 |
| Operating Cash Flow | $-1,595 | $-35,947 | $-34,388 | $-17,685 | $-14,751 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -133 | -133 | -133 | -126 |
| Investing Cash Flow | $N/A | $-133 | $-133 | $-133 | $-126 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -225 | -17,375 | -17,150 | -5,000 | -5,000 |
| Common Stock Issued | 1,003 | 35,430 | 34,544 | 12,573 | 348 |
| Other Financing Activity | 0 | 4,128 | 4,129 | 4,129 | 4,129 |
| Financing Cash Flow | $778 | $22,183 | $21,523 | $11,702 | $-523 |
| Beginning Cash Position | 5,246 | 19,143 | 19,143 | 19,143 | 19,143 |
| End Cash Position | 4,429 | 5,246 | 6,145 | 13,027 | 3,743 |
| Net Cash Flow | $-817 | $-13,897 | $-12,998 | $-6,116 | $-15,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,595 | -35,947 | -34,388 | -17,685 | -14,751 |
| Capital Expenditure | N/A | -133 | -133 | -133 | -126 |
| Free Cash Flow | -1,595 | -36,080 | -34,521 | -17,818 | -14,877 |